CFTR and breast carcinoma: As CHIP-dependent degradation of newly synthesized CFTR occurs in the ER, through ERAD, we asked whether a similar process accounts for CHIP-dependent degradation of newly synthesized ErbB2 in ErbB2-overexpressing breast cancer cells.